Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.73B | 20.73B | 21.60B | 22.15B | 18.47B | 21.85B | Gross Profit |
5.08B | 5.91B | 6.74B | 4.44B | 5.09B | 5.95B | EBIT |
-873.00M | 255.00M | 794.00M | -997.00M | 255.00M | 407.00M | EBITDA |
-325.00M | 896.00M | 1.48B | -425.00M | 810.00M | 1.02B | Net Income Common Stockholders |
-1.09B | 235.00M | 679.00M | -1.07B | 178.00M | 444.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.42B | 4.20B | 6.78B | 4.48B | 5.66B | 6.13B | Total Assets |
31.22B | 28.84B | 30.61B | 28.96B | 27.40B | 25.02B | Total Debt |
10.70B | 9.70B | 8.27B | 8.29B | 7.81B | 5.52B | Net Debt |
7.28B | 5.50B | 1.73B | 3.81B | 2.14B | -609.00M | Total Liabilities |
19.30B | 15.18B | 16.93B | 16.25B | 13.69B | 11.54B | Stockholders Equity |
11.92B | 13.66B | 13.69B | 12.71B | 13.71B | 13.49B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.85B | 2.65B | -1.52B | -2.60B | 434.00M | Operating Cash Flow |
0.00 | -3.52B | 2.96B | -1.19B | -1.62B | 1.16B | Investing Cash Flow |
0.00 | -527.00M | -778.00M | -335.00M | -985.00M | -728.00M | Financing Cash Flow |
0.00 | 1.10B | -246.00M | 272.00M | 2.06B | -708.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥42.34B | 11.72 | 6.17% | 3.23% | -22.14% | ||
80 Outperform | ¥23.42B | 6.65 | 4.09% | 7.38% | 25.89% | ||
79 Outperform | ¥3.55B | 3.41 | ― | 3.30% | 37.00% | ||
74 Outperform | ¥41.87B | 14.19 | 3.98% | -1.34% | -14.87% | ||
62 Neutral | $11.93B | 10.60 | -7.51% | 3.00% | 7.40% | -8.09% | |
58 Neutral | ¥3.94B | 16.82 | 1.94% | -4.02% | -65.44% | ||
58 Neutral | ¥5.98B | 570.19 | 3.10% | -22.01% | ― |